Overview

Epigenetics Market is anticipated to value over CAGR of over 13% during the forecast period 2022 to 2028.

The availability of funds to conduct research on epigenetics, the decrease in the sequencing costs, increase in the number of patients diagnosed with cancer are some of the primary reasons accountable for the growth of the epigenetics market. There is an ongoing research pertaining to the usage of epigenetics on non-oncological diseases and with the emergence of targeted therapy, it is predicted that the market will grow remarkably owing to these factors. 
FutureWise Market Research has instantiated a report that provides an intricate analysis of Epigenetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Epigenetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Epigenetics Market:

• Illumina
• Thermo Fisher Scientific
• Merck Millipore
• Abcam
• Active Motif
• Bio-Rad
• New England Biolabs
• Agilent
• Qiagen
• Zymo Research
• Perkinelmer
• Diagenode

(Note: The list of the major players will be updated with the latest market scenario and trends)

Epigenetics Market Segmentation:

By Product

• Enzymes
  o DNA-modifying Enzymes
  o Protein-modifying Enzymes
  o RNA-modifying Enzymes
• Instruments and Consumables
  o Next-generation Sequencers
  o qPCR
  o Mass Spectrometers
  o Sonicators
  o Others
• Kits
  o Bisulfite Conversion Kits
  o ChIP-sequencing Kits
  o RNA sequencing Kits
  o Whole Genomic Amplification Kits
  o 5-hmC and 5-mC Analysis Kits
  o Others
• Reagents
  o Antibodies
  o Buffers
  o Histones
  o Magnetic Beads
  o Primers
  o Others
• Bioinformatics Tools

By Application

• Oncology
• Metabolic Diseases
• Developmental Biology
• Immunology
• Cardiovascular Diseases
• Others

By Technology

• DNA Methylation
• Histone Modifications
• Others

By End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Epigenetics Market By Product, By Application, By Technology, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
         2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
         2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Epigenetics Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Epigenetics Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Epigenetics Market Analysis Tools

       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Epigenetics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
       7.1. Enzymes
              7.1.1. DNA-modifying Enzymes
              7.1.2. Protein-modifying Enzymes
              7.1.3. RNA-modifying Enzymes
       7.2. Instruments and Consumables 
              7.2.1. Next-generation Sequencers
              7.2.2. qPCR
              7.2.3. Mass Spectrometers
              7.2.4. Sonicators
              7.2.5. Others
       7.3. Kits
              7.3.1. Bisulfite Conversion Kits
              7.3.2. ChIP-sequencing Kits
              7.3.3. RNA sequencing Kits
              7.3.4. Whole Genomic Amplification Kits
              7.3.5. 5-hmC and 5-mC Analysis Kits
              7.3.6. Others 
       7.4. Reagents
              7.4.1. Antibodies
              7.4.2. Buffers
              7.4.3. Histones
              7.4.4. Magnetic Beads
              7.4.5. Primers
              7.4.6. Others
       7.5. Bioinformatics 

8. Global Epigenetics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
       8.1. Oncology
       8.2. Metabolic Diseases
       8.3. Developmental Biology
       8.4. Immunology
       8.5. Cardiovascular Diseases
       8.6. Others

9. Global Epigenetics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
       9.1. DNA Methylation
       9.2. Histone Modifications
       9.3. Others

10. Global Epigenetics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
       10.1. Academic and Research Institutes
       10.2. Pharmaceutical and Biotechnology Companies
       10.3. Contract Research Organizations (CROs)

11.  North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            11.2.1. U.S.A
            11.2.2. Canada
            11.2.3. Mexico
       11.3. Market Size (USD Million) Forecast for North America 2022-2028

12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       12.1. Introduction
       12.2. Regional Market Trends
       12.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            12.3.1. Brazil
            12.3.2. Venezuela
            12.3.3. Argentina
            12.3.4. Rest of Latin America
       12.4. Market Size (USD Million) Forecast for Latin America 2022-2028

13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
               13.2.1. Germany
               13.2.2. U.K
               13.2.3. France
               13.2.4. Italy
               13.2.5. Spain
               13.2.6. Russia
               13.2.7. Poland
               13.2.8. Switzerland
               13.2.9. Rest of Western Europe

14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       14.1. Introduction
       14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             14.2.1. Japan
             14.2.2. China
             14.2.3. Singapore
             14.2.4. India
             14.2.5. Australia and New Zealand
             14.2.6. ASEAN
             14.2.7. South Korea
             14.2.8. Rest of Asia Pacific
       14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028

15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       15.1. Introduction
       15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             15.2.1. GCC
             15.2.2. Israel
             15.2.3. South Africa
             15.2.4. Rest of MEA
       15.3. Market Size (USD Million) Forecast for MEA 2022-2028

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       16.1. Illumina
                16.1.1. Company Overview
                16.1.2. Product Portfolio
                16.1.3. SWOT Analysis
                16.1.4. Financial Overview
                16.1.5. Strategic Overview
       16.2. Thermo Fisher Scientific
                16.2.1. Company Overview
                16.2.2. Product Portfolio
                16.2.3. SWOT Analysis
                16.2.4. Financial Overview
                16.2.5. Strategic Overview
       16.3. Merck Millipore
                16.3.1. Company Overview
                16.3.2. Product Portfolio
                16.3.3. SWOT Analysis
                16.3.4. Financial Overview
                16.3.5. Strategic Overview
       16.4. Abcam
                16.4.1. Company Overview
                16.4.2. Product Portfolio
                16.4.3. SWOT Analysis
                16.4.4. Financial Overview
                16.4.5. Strategic Overview
       16.5. Active Motif
                16.5.1. Company Overview
                16.5.2. Product Portfolio
                16.5.3. SWOT Analysis
                16.5.4. Financial Overview
                16.5.5. Strategic Overview
       16.6. Bio-Rad
                16.6.1. Company Overview
                16.6.2. Product Portfolio
                16.6.3. SWOT Analysis
                16.6.4. Financial Overview
                16.6.5. Strategic Overview
       16.7. New England Biolabs
                16.7.1. Company Overview
                16.7.2. Product Portfolio
                16.7.3. SWOT Analysis
                16.7.4. Financial Overview
                16.7.5. Strategic Overview
       16.8. Agilent
                16.8.1. Company Overview
                16.8.2. Product Portfolio
                16.8.3. SWOT Analysis
                16.8.4. Financial Overview
                16.8.5. Strategic Overview
       16.9. Qiagen
                16.9.1. Company Overview
                16.9.2. Product Portfolio
                16.9.3. SWOT Analysis
                16.9.4. Financial Overview
                16.9.5. Strategic Overview
       16.10. Zymo Research
                16.10.1. Company Overview
                16.10.2. Product Portfolio
                16.10.3. SWOT Analysis
                16.10.4. Financial Overview
                16.10.5. Strategic Overview
       16.11. Perkinelmer
                16.11.1. Company Overview
                16.11.2. Product Portfolio
                16.11.3. SWOT Analysis
                16.11.4. Financial Overview
                16.11.5. Strategic Overview
       16.12. Diagenode
                16.12.1. Company Overview
                16.12.2. Product Portfolio
                16.12.3. SWOT Analysis
                16.12.4. Financial Overview
                16.12.5. Strategic Overview

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME key takeaway points for Client

Tables

Figures